| Stage | HRB | % of rev | SCI | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $2.4B | 100.00% | $1.1B | 100.00% | HRB ×2.17 |
| Gross profit | $1.4B | 56.97% | $272M | 24.59% | HRB +32.4pp |
| Operating income | $1.0B | 43.24% | $253M | 22.84% | HRB +20.4pp |
| Pre-tax income | $1.0B | 42.39% | $189M | 17.05% | HRB +25.3pp |
| Net income | $848M | 35.36% | $141M | 12.76% | HRB +22.6pp |
| Stage | HRB | SCI | Gap · A − B |
|---|---|---|---|
| Revenue | $2.4B100.00% | $1.1B100.00% | HRB ×2.17 |
| Gross profit | 56.97%$1.4B | 24.59%$272M | HRB +32.4pp |
| Operating income | 43.24%$1.0B | 22.84%$253M | HRB +20.4pp |
| Pre-tax income | 42.39%$1.0B | 17.05%$189M | HRB +25.3pp |
| Net income |
| 35.36%$848M |
| 12.76%$141M |
| HRB +22.6pp |
No disclosed counterparties: SCI.
None